| Dr Sidney Alexander, MD | |
|
Lahey Clinic, 41 Mall Road, Burlington, MA 01805-0001 | |
| (781) 744-8461 | |
| (781) 744-5261 |
| Full Name | Dr Sidney Alexander |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 67 Years |
| Location | Lahey Clinic, Burlington, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508965351 | NPI | - | NPPES |
| 6167233 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25725 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Winchester Hospital | Winchester, MA | Hospital |
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lahey Clinic Inc | 2264336528 | 1211 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.
Knowing which risks may come into play before or during surgery is especially important where children are concerned.
› Verified 1 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.
Knowing which risks may come into play before or during surgery is especially important where children are concerned.
› Verified 1 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.
Knowing which risks may come into play before or during surgery is especially important where children are concerned.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sidney Alexander, MD Lahey Clinic, 41 Mall Road, Burlington, MA 01805-0001 Ph: (781) 744-8461 | Dr Sidney Alexander, MD Lahey Clinic, 41 Mall Road, Burlington, MA 01805-0001 Ph: (781) 744-8461 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.
Knowing which risks may come into play before or during surgery is especially important where children are concerned.
› Verified 1 days ago
Joseph Dubin, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd., Lahey Clinic, Burlington, MA 01805 Phone: 781-744-7000 Fax: 781-744-5378 | |
Gerard Daly, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-5700 Fax: 781-744-5358 | |
Sahoor Khan, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Kristen M Robson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8699 Fax: 781-744-5276 | |
Eric Scott Kerns, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Lahey Hospital & Medical Center, Burlington, MA 01805 Phone: 781-744-8430 Fax: 781-744-5397 | |
Neethi Rebekah Dasu, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Frederick W Heiss, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-5100 |